Enstilar (Betamethasone, Calcipotriol)

Enstilar is a topical medication combining betamethasone and calcipotriol for skin conditions. It's designed for cutaneous use and is manufactured by Leo Pharma A/S in the EU.

Enstilar is primarily used for the treatment of plaque psoriasis, a common skin disorder. The combination of betamethasone and calcipotriol works to reduce inflammation and promote skin cell turnover. This medication is applied directly to the affected areas of the skin.

When used as directed, Enstilar may help to reduce redness, itching, and scaling associated with plaque psoriasis. Users often notice improvements in skin appearance and comfort. However, individual results can vary.

Enstilar should be used exactly as prescribed by a healthcare professional. It is important to follow the instructions provided to avoid potential side effects. Avoid contact with eyes, mouth, and broken skin. Always consult a healthcare provider before starting any new medication.

Enstilar may interact with other topical medications or treatments. It is advisable to inform your healthcare provider about all current medications, including over-the-counter drugs and supplements. Avoid using other topical treatments on the same area without medical advice.